{Reference Type}: Case Reports
{Title}: Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report.
{Author}: Yomota M;Tanaka M;Kobayashi T;Kitano M;Ikeda S;Kanemasa Y;Yanagawa N;Hosomi Y;
{Journal}: Respirol Case Rep
{Volume}: 12
{Issue}: 2
{Year}: 2024 Feb
暂无{DOI}: 10.1002/rcr2.1298
{Abstract}: We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.